NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine -

Categories: Associated Press


Thoughtful and thorough, AP story looks at growing trend of using ketamine for depression


AP offers strong reporting about the evidence for a drug treatment for moderate bone loss


Multigene test may find risk for common diseases, but there’s no evidence it will make anyone healthier


Diagnosing Alzheimer’s using biomarkers–AP makes it clear that there is no benefit to patients


AP story on ‘selfie medicine’ adherence programs overlooked evidence showing they don’t work well


AP’s widely-reported story on IV fluids oversimplified the research


‘It’s unknown whether treatment increases survival,’ AP wisely notes about new breast cancer drug

1 11/28/2017

Patient anecdote outweighs data in AP’s look at lymph node transfer surgery

5 10/25/2017

Brief but informative report from AP on newly approved shingles vaccine


AP makes it clear that gene therapy has uncertain future for treating ALD